Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

The PRS was significantly correlated with an increased vitamin D level among both CRC cases (P = 1.60 × 10−8 in SOCCS and P < 2 × 10−16 in UKBB) and non-CRC participants (P = 2.61 × 10−6 in SOCCS and P < 2 × 10−16 in UKBB; Table S11).

Source: Mendelian randomisation study. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Genetic instrumental-variable study.

Genetic instrumental-variable study

Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.

Meta-analysis reported · Blinding unclear / not reported · Research setting awaiting verification

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Circulating 25-hydroxyvitamin D and survival outcomes of colorectal cancer: evidence from population-based prospective cohorts and Mendelian randomisation

Source: Article title.

Fixed-effect meta-analysis was performed to pool the estimates from the two datasets.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Circulating 25-hydroxyvitamin D and survival outcomes of colorectal cancer: evidence from population-based prospective cohorts and Mendelian randomisation

Genetic instrumental-variable study · British Journal of Cancer · 2024

Original publication title

Circulating 25-hydroxyvitamin D and survival outcomes of colorectal cancer: evidence from population-based prospective cohorts and Mendelian randomisation

Xiaomeng Zhang; Yazhou He; Xue Li; Rasha Shraim; Wei Xu; Lijuan Wang; Susan M. Farrington; Harry Campbell; Maria Timofeeva; Lina Zgaga; Peter Vaughan-Shaw; Evropi Theodoratou; Malcolm G. Dunlop

© The Author(s) 2024

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

This study supports the observed association between lower circulating 25-OHD and poorer survival outcomes for CRC patients. Whilst the genotype-specific association between better outcomes and higher 25-OHD is intriguing, we found no support for causality using MR approaches.

An extract from the source publication. Read it in context.

At a glance

Abstract: What background does the paper provide?

To investigate the association between circulating 25-hydroxyvitamin D (25-OHD) and colorectal cancer (CRC) survival outcomes.

Source: Background

Abstract: What methods does the paper describe?

We conducted analyses among the Study of Colorectal Cancer in Scotland (SOCCS) and the UK Biobank (UKBB). Both cancer-specific survival (CSS) and overall survival (OS) outcomes were examined. The 25-OHD levels were categorised into three groups, and multi-variable Cox-proportional hazard models were applied to estimate hazard ratios (HRs). We performed individual-level Mendelian randomisation (MR) through the generated polygenic risk scores (PRS) of 25-OHD and summary-level MR using the inverse-variance weighted (IVW) method.

Source: Methods

Abstract: Results

We observed significantly poorer CSS (HR = 0.65,95%CI = 0.55 to 0.76,P = 1.03 × 10−7) and OS (HR = 0.66,95%CI = 0.58 to 0.75,P = 8.15 × 10−11) in patients with the lowest compared to those with the highest 25-OHD after adjusting for covariates. These associations remained across patients with varied tumour sites and stages. However, we found no significant association between 25-OHD PRS and either CSS (HR = 0.98,95%CI = 0.80 to 1.19,P = 0.83) or OS (HR = 1.07,95%CI = 0.91 to 1.25,P = 0.42).

Furthermore, we found no evidence for causal effects by conducting summary-level MR analysis for either CSS (IVW:HR = 1.04,95%CI = 0.85 to 1.28,P = 0.70) or OS (IVW:HR = 1.10,95%CI = 0.93 to 1.31,P = 0.25).

Source: Results

Abstract: Conclusion

This study supports the observed association between lower circulating 25-OHD and poorer survival outcomes for CRC patients. Whilst the genotype-specific association between better outcomes and higher 25-OHD is intriguing, we found no support for causality using MR approaches.

Source: Conclusion
Authors’ abstract

Background

To investigate the association between circulating 25-hydroxyvitamin D (25-OHD) and colorectal cancer (CRC) survival outcomes.

Methods

We conducted analyses among the Study of Colorectal Cancer in Scotland (SOCCS) and the UK Biobank (UKBB). Both cancer-specific survival (CSS) and overall survival (OS) outcomes were examined. The 25-OHD levels were categorised into three groups, and multi-variable Cox-proportional hazard models were applied to estimate hazard ratios (HRs). We performed individual-level Mendelian randomisation (MR) through the generated polygenic risk scores (PRS) of 25-OHD and summary-level MR using the inverse-variance weighted (IVW) method.

Results

We observed significantly poorer CSS (HR = 0.65,95%CI = 0.55 to 0.76,P = 1.03 × 10−7) and OS (HR = 0.66,95%CI = 0.58 to 0.75,P = 8.15 × 10−11) in patients with the lowest compared to those with the highest 25-OHD after adjusting for covariates. These associations remained across patients with varied tumour sites and stages. However, we found no significant association between 25-OHD PRS and either CSS (HR = 0.98,95%CI = 0.80 to 1.19,P = 0.83) or OS (HR = 1.07,95%CI = 0.91 to 1.25,P = 0.42).

Furthermore, we found no evidence for causal effects by conducting summary-level MR analysis for either CSS (IVW:HR = 1.04,95%CI = 0.85 to 1.28,P = 0.70) or OS (IVW:HR = 1.10,95%CI = 0.93 to 1.31,P = 0.25).

Conclusion

This study supports the observed association between lower circulating 25-OHD and poorer survival outcomes for CRC patients. Whilst the genotype-specific association between better outcomes and higher 25-OHD is intriguing, we found no support for causality using MR approaches.

Publication and source details

Original title: Circulating 25-hydroxyvitamin D and survival outcomes of colorectal cancer: evidence from population-based prospective cohorts and Mendelian randomisation

Xiaomeng Zhang; Yazhou He; Xue Li; Rasha Shraim; Wei Xu; Lijuan Wang; Susan M. Farrington; Harry Campbell; Maria Timofeeva; Lina Zgaga; Peter Vaughan-Shaw; Evropi Theodoratou; Malcolm G. Dunlop

British Journal of Cancer · 2024

© The Author(s) 2024https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.Darwin Trust of EdinburghChina Scholarship Councilhttps://doi.org/10.13039/501100000289Cancer Research UK (CRUK)C31250/A22804C348/A18927Theodoratou Evropi Dunlop Malcolm G.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T04:41:23.406861+00:00

DOI: 10.1038/s41416-024-02643-5 · PMC11058806